These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23640355)

  • 21. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses.
    Cotroneo AR; Pascali D; Iezzi R
    J Endovasc Ther; 2008 Jun; 15(3):283-91. PubMed ID: 18540701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
    J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
    Cassese S; Byrne RA; Ott I; Ndrepepa G; Nerad M; Kastrati A; Fusaro M
    Circ Cardiovasc Interv; 2012 Aug; 5(4):582-9. PubMed ID: 22851526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-eluting stents for the treatment of femoropopliteal arterial stenoses: focus on the Zilver PTX drug-eluting peripheral stent.
    Moukarbel GV; Burket MW
    Expert Rev Med Devices; 2015 Mar; 12(2):157-62. PubMed ID: 25418344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
    Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
    Siablis D; Katsanos K; Karnabatidis D
    J Endovasc Ther; 2010 Aug; 17(4):488-91. PubMed ID: 20681764
    [No Abstract]   [Full Text] [Related]  

  • 29. Regarding "Stenting for femoropopliteal lesions".
    Schillinger M; Minar E
    J Vasc Surg; 2008 Jul; 48(1):252; author reply 252-3. PubMed ID: 18589243
    [No Abstract]   [Full Text] [Related]  

  • 30. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which is currently the best strategy for treatment of SFA in-stent restenosis?
    Elens M; Verbist J; Keirse K; Van Den Eynde W; Peeters P
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):477-81. PubMed ID: 24941234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-coated balloons in the lower limb.
    Zeller T; Schmitmeier S; Tepe G; Rastan A
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):235-43. PubMed ID: 21460774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refining stent technologies for femoral interventions.
    Bosiers M; Deloose K; Callaert J; Maene L; Keirse K; Verbist J; Peeters P
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):465-73. PubMed ID: 22854526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does below-the-knee placement of drug-eluting stents improve clinical outcomes?
    Katsanos K; Spiliopoulos S; Krokidis M; Karnabatidis D; Siablis D
    J Cardiovasc Surg (Torino); 2012 Apr; 53(2):195-203. PubMed ID: 22456642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):331-8. PubMed ID: 22440500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regarding: Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?
    Teebken OE; Bauermeister G; Pichlmaier AM
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):118. PubMed ID: 18440251
    [No Abstract]   [Full Text] [Related]  

  • 37. [Endovascular therapy options in femoro-popliteal PAD].
    Brechtel K
    Rofo; 2010 Sep; 182(9):755-63. PubMed ID: 20603777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What are the potential limitations of drug coated balloons and possible ways to overcome.
    Werk M
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
    Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ;
    J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interventional treatment of peripheral artery occlusive disease].
    Schmidt A; Scheinert D
    Dtsch Med Wochenschr; 2014 Oct; 139(40):1979-81. PubMed ID: 25254390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.